Abstract
A number of anticoagulants are found in plasma, helping to maintain the balance between thrombosis and haemorrhage. Two of the most important are antithrombin and protein C, which inactivates factors V and VIII. Deficiencies are well-recognised predisposing factors for systemic thrombosis. To establish whether the factor V or Cambridge II antithrombin mutations were present with an increased frequency in patients with idiopathic central retinal vein occlusion (CRVO) we screened 50 such patients. DNA was isolated and the regions of the gene encoding for factor V and antithrombin were amplified by means of the polymerase chain reaction. Following digestion with restriction enzymes the products were electrophoresed in agarose gels. We identified a single patient with the factor V mutation and none with the antithrombin mutation. These findings suggest that resistance to activated protein C and antithrombin mutations does not play a major role in CRVO.
Similar content being viewed by others
Article PDF
References
Verhoeff FH . Obstruction of the central retinal vein. Arch Ophthalmol 1907;36:1–0.
Green WR, Chan CC, Hutchins GM, et al. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27–0.
Glacet-Bernard A, Chabanel A, Lelong F, Samama M, Coscas G . Elevated erythrocyte aggregation in patients with CRVO with and without conventional risk factors. Ophthalmology 1994;101:1483–7.
Bandello F, Vigario S, Parlavecchia M, et al. Hypercoagulability and high lipoprotein levels in patients with CRVO. Thromb Haemost 1994;72:39–43.
Sanborn GE, Magargal LE, Jaeger EA . Venous occlusive disease of the retina. In: Duanes clinical ophthalmology, part 3(15), 1988:1–22.
Pliszkiewicz K, Pournaras C, Roth A . Thrombose veineuse oculaire pathologie vasculaire générale. Klin Monatsbl Augenheilkd 1984;184:367–0.
McGrath MA, Wechsler F, Hunyor ABL, et al. Systemic factors contributing to retinal vein occlusion. Arch Intern Med 1978;138:216–0.
Dodson PM, Clough CG, Dowries SM, Kritzinger EE . Does type II diabetes predispose to retinal vein occlusion? Eur J Ophthalmol 1993;3:109–13.
Dodson PM, Galton DJ, Winder AF . Retinal vascular abnormalities in the hyperlipidaemias. Trans Ophthalmol Soc UK 1981;101:17–0.
Vannas S, Tarkkanen A . Retinal vein occlusion and glaucoma: tonographic study of the incidence of glaucoma and of its prognostic significance. Br J Ophthalmol 1960;44:583–0.
Hayreh SS, March W, Phelps CD . Ocular hypotony following CRVO. Arch Ophthalmol 1978;96:827–33.
Heyreh SS, Zimmerman MB, Podhajsky P, Alward WLM . Nocturnal arterial hypotension and its role in optic nerve head and ocular ischaemic disorders. Am J Ophthalmol 1994;117:603–24.
Dittman WA, Majerus PW . Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990;75:329–36.
Bertina RM, Koeleman RPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–7.
Dahlback B, Hildebrand B . Inherited resistance to activated protein C is corrected by anticoagulant factor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994;91:1396–400.
Svensson PJ, Dahlback B . Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1993;330:517–22.
Gladson CL, Griffin JH, Hach V, et al. The incidence of protein C and protein S deficiency in young thrombotic patients. Blood 1985;66(Suppl):350–0.
Delbert GR, Cosgriff PM, Martin B . Central retinal vein occlusion in a patient with familial antithrombin III deficiency. Ann Ophthalmol 1979;11:1841–0.
Soukiasian S, Lahav M, Snady-McCoy L . Natural anticoagulants in retinal vein occlusions. Invest Ophthalmol Vis Sci 1989;30:477–0.
Dahlback B, Carlsson M, Svensson PJ . Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–8.
Neetens IM, Talbot JF, Preston FE . Bilateral retinal branch vein occlusion in protein C deficiency. Bull Soc Belge Ophtalmol 1987;223:53–7.
Chung MM, Trese MT, Hong YJ . Protein C levels in retinal vein occlusions. Invest Ophthalmol Vis Sci 1989;30:477–0.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgkins, P., Perry, D., Sawcer, S. et al. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye 9, 760–762 (1995). https://doi.org/10.1038/eye.1995.191
Issue Date:
DOI: https://doi.org/10.1038/eye.1995.191
Keywords
This article is cited by
-
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Journal of Thrombosis and Thrombolysis (2016)
-
Central retinal vein occlusion and thrombophilia
Eye (2002)
-
Familial thrombophilia and retinal vein occlusion
Eye (2000)